Xác định và Đặc trưng hóa một Inhibitor Mới và Đặc hiệu của Kinase ATM Đột biến Ataxia-Telangiectasia

Rouse J, Jackson SP Interfaces between the detection, signaling and repair of DNA damage. Science (Wash. DC) 2002; 297: 547-51.

Zakian VA ATM-related genes: what do they tell us about functions of the human gene?. Cell 1995; 82: 685-7.

Abraham RT Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001; 15: 2177-96.

Shiloh Y ATM and related protein kinases: safeguarding genome integrity. Nat Cancer Rev 2003; 3: 155-68.

Lavin MF, Shiloh Y The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 1997; 15: 177-202.

Rotman G, Shiloh Y ATM. from gene to function. Hum Mol Genet 1988; 7: 1555-63.

Kastan MB, Lim DS The many substrates and functions of ATM. Nat Rev Mol Cell Biol 2000; 1: 179-86.

Shiloh Y ATM and ATR: networking cellular responses to DNA damage. Curr Opin Genet Dev 2001; 11: 71-7.

Xu B, Kim ST, Lim DS, Kastan MB Two molecularly distinct G2-M checkpoints are induced by ionizing irradiation. Mol Cell Biol 2002; 22: 1049-59.

Canman CE, Lim DS, Cimprich KA, et al Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (Wash. DC) 1988; 281: 1677-9.

Banin S, Moyal L, Shieh S, et al Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (Wash. DC) 1998; 281: 1674-7.

Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci 2000; 97: 10389-94.

Maya R, Balass M, Kim ST, et al ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev 1999; 15: 1067-77.

Zhao S, Weng YC, Yuan SS, et al Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature (Lond.) 2000; 405: 473-7.

Bao S, Tibbetts RS, Brumbaugh KM, et al ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses. Nature (Lond.) 2001; 411: 969-74.

Xu B, Kim ST, Kastan MB Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001; 21: 3445-50.

Fornace AL, Jr, Little JB Normal repair of DNA single-strand breaks in patients with ataxia-telangiectasia. Biochem Biophys Acta 1980; 607: 432-7.

Lavin MF, Davidson M Repair of strand breaks in superhelical DNA of ataxia-telangiectasia lymphoblastoid cells. J Cell Sci 1981; 48: 383-91.

Cornforth MN, Bedford JS On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science (Wash. DC) 1985; 227: 1589-91.

Coquerelle TM, Weibezahn KF, Lucke-Huhle C Rejoining of double strand breaks in normal human and ataxia-telangiectasia fibroblasts after exposure to 60Co gamma-rays, 241Am alpha-particles or bleomycin. Int J Radiat Biol Relat Stud Phys Chem Med 1987; 51: 209-18.

Foray N, Priestley A, Alsbeih G, et al Hypersensitivity of ataxia-telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int J Radiat Biol 1997; 72: 271-83.

Sarkaria JN, Eshleman JS ATM as a target for novel radiosensitizers. Semin Radiat Oncol 2001; 11: 316-27.

Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res 1998; 58: 4375-82.

Izzard RA, Jackson SP, Smith GCM Competitive and non-competitive inhibition of the DNA dependent protein kinase. Cancer Res 1999; 59: 2581-6.

Ui M, Okada T, Hazeki K, Hazeki O Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci 1995; 20: 303-7.

Zhou B-B S, Chaturvedi P, Spring K, et al Caffeine abolishes the mammalian G2-M DNA damage checkpoint by inhibiting ataxia-telangiectasia–mutated kinase activity. J Biol Chem 2000; 5: 10342-8.

Block WD, Merkle D, Meek K, Lees-Miller SP Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine. Nucleic Acid Res 2004; 32: 1967-72.

Vlahos CJ, Matter WF, Hui KY, Brown RF A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269: 5241-8.

Blunt T, Finnie NJ, Taccioli GE, et al Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995; 80: 813-23.

Tibbetts RS, Brumbaugh KM, Williams JM, et al A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13: 152-7.

Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC, Abraham RT Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 1996; 15: 5256-67.

Veuger SJ, Curtin NJ, Richardson CJ, Smith GCM, Durkacz BW Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly (ADP-ribose) polymerase-1. Cancer Res 2003; 63: 6008-15.

Zhao X-H, Bondeva T, Balla T Characterization of recombinant phosphatidylinositol 4-kinase beta reveals auto- and heterophosphorylation of the enzyme. J Biol Chem 2000; 275: 14642-8.

Allan LA, Fried M p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis. Oncogene 1999; 18: 5403-12.

Ormerod MG Analysis of DNA-general methods Ormerod MG eds. . Flow cytometry 200083-97. Oxford University Press Oxford, UK

Walker EH, Pacold ME, Perisic O, et al Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 2000; 6: 909-19.

Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276: 42462-7.

Lim DS, Kim ST, Xu B, et al ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature (Lond.) 2000; 404: 613-7.

Liu Q, Guntuku S, Cui XS, et al Chk1 is an essential kinase that is regulated by Atr and required for the G2-M DNA damage checkpoint. Genes Dev 2000; 14: 1448-59.

Kim ST, Xu B, Kastan MB Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev 2002; 16: 560-70.

Caporossi D, Porfirio B, Nicoletti B, et al Hypersensitivity of lymphoblastoid lines derived from ataxia-telangiectasia patients to the induction of chromosomal aberrations by etoposide (VP-16). Mutat Res 1993; 290: 265-72.

Henner WD, Blazka ME Hypersensitivity of cultured ataxia-telangiectasia cells to etoposide. J Natl Cancer Inst (Bethesda) 1986; 76: 1007-11.

Fedier A, Schlamminger M, Schwarz VA, Haller U, Howell SB, Fink D Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites. Ann Oncol 2003; 14: 938-45.

Canman CE, Wolff AC, Chen C-Y, Fornace AJ, Jr, Kastan MB The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res 1994; 54: 5054-8.

Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 1999; 96: 13777-82.

Stiff T, O’Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 2004; 64: 2390-6.

Bakkenist CJ, Kastan MB DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature (Lond.) 2003; 421: 499-506.

Gosink EC, Chong MJ, McKinnon PJ Ataxia-telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity. Cancer Res 1999; 59: 5294-8.

Takimoto CH, Arbuck SG Topoisomerase I targeting agents: the camptothecins Chabner BA Longo DL eds. . Cancer chemotherapy and biotherapy: principles and practice 2001579-646. Lippincott, Williams and Wilkins Philadelphia

Smith PJ, Makinson TA, Watson JV Enhanced sensitivity to camptothecin in ataxia-telangiectasia cells and its relationship with the expression of DNA topoisomerase I. Int J Radiat Biol 1989; 55: 217-31.

Pommier YG, Goldwasser F, Strumberg D Topoisomerase II inhibitors: epipodophyllotoxins, acridines, ellipticines, and bisdioxopiperazines Chabner BA Longo DL eds. . Cancer chemotherapy and biotherapy: principles and practice 2001538-78. Lippincott, Williams & Wilkins Philadelphia

Shiloh Y, Becker Y Kinetics of O6-methylguanine repair in human normal and ataxia-telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents. Cancer Res 1981; 41: 5114-20.

Jaspers NG, de Wit J, Regulski MR, Bootsma D Abnormal regulation of DNA replication and increased lethality in ataxia-telangiectasia cells exposed to carcinogenic agents. Cancer Res 1982; 42: 335-41.

Zhang N, Chen P, Gatei M, Scott S, Khanna KK, Lavin MF An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells. Oncogene 1998; 17: 811-8.

Uhrhammer N, Fritz E, Boyden L, Meyn MS Human fibroblasts transfected with an ATM antisense vector respond abnormally to ionizing radiation. Int J Mol Med 1999; 4: 43-7.

Guha C, Guha U, Tribius S, et al Antisense ATM gene therapy: a strategy to increase the radiosensitivity of human tumors. Gene Ther 2000; 7: 852-8.

Collis SJ, Swartz MJ, Nelson WG, DeWeese TL Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res 2003; 63: 1550-4.